nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A new paradigm is needed for financing the pandemic fund
|
Reid-Henry, Simon |
|
|
400 |
10349 |
p. 345-346 |
artikel |
2 |
Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality
|
Mehta, Puja |
|
|
400 |
10349 |
p. 338-339 |
artikel |
3 |
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
|
|
|
|
400 |
10349 |
p. 359-368 |
artikel |
4 |
Bronchiolitis
|
Dalziel, Stuart R |
|
|
400 |
10349 |
p. 392-406 |
artikel |
5 |
Calvarium indentations in multiple myeloma and CAR T-cell therapy
|
Munoz, Javier |
|
|
400 |
10349 |
p. 391 |
artikel |
6 |
Cathie Sudlow: devoted to data
|
Watts, Geoff |
|
|
400 |
10349 |
p. 351 |
artikel |
7 |
Department of Error
|
|
|
|
400 |
10349 |
p. 358 |
artikel |
8 |
Department of Error
|
|
|
|
400 |
10349 |
p. 358 |
artikel |
9 |
Department of Error
|
|
|
|
400 |
10349 |
p. 358 |
artikel |
10 |
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial
|
Kim, Byeong-Keuk |
|
|
400 |
10349 |
p. 380-390 |
artikel |
11 |
Lowering LDL cholesterol in clinical practice: time for change?
|
Abushamat, Layla A |
|
|
400 |
10349 |
p. 341-343 |
artikel |
12 |
Lower taxes or greater health equity
|
Marmot, Michael |
|
|
400 |
10349 |
p. 352-353 |
artikel |
13 |
Monkeypox: a global wake-up call
|
The Lancet, |
|
|
400 |
10349 |
p. 337 |
artikel |
14 |
Monkeypox PHEIC decision hoped to spur the world to act
|
Zarocostas, John |
|
|
400 |
10349 |
p. 347 |
artikel |
15 |
New Dutch regulations to alleviate drug shortages
|
Biedermann, Ferry |
|
|
400 |
10349 |
p. 349-350 |
artikel |
16 |
Perilous two-tier COVID-19 global vaccine roll-out
|
Durrheim, David N |
|
|
400 |
10349 |
p. 355-356 |
artikel |
17 |
Reforms to accelerated approval of new medicines: long overdue
|
Hwang, Thomas J |
|
|
400 |
10349 |
p. 357-358 |
artikel |
18 |
SOS Brazil: democracy under attack
|
Hallal, Pedro C |
|
|
400 |
10349 |
p. 355 |
artikel |
19 |
The Health and Care Act 2022: challenges and priorities for embedding research in the NHS
|
Toh, Cheng Hock |
|
|
400 |
10349 |
p. 343-345 |
artikel |
20 |
Tobacco company funding and conflict of interest
|
Pattemore, Philip |
|
|
400 |
10349 |
p. 356 |
artikel |
21 |
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis
|
Liew, Jean W |
|
|
400 |
10349 |
p. 340-341 |
artikel |
22 |
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Deodhar, Atul |
|
|
400 |
10349 |
p. 369-379 |
artikel |
23 |
Urgent need to update NICE guidelines on imaging for transient ischaemic attack
|
MacSweeney, Shane |
|
|
400 |
10349 |
p. 357 |
artikel |
24 |
Urvashi Vaid
|
Green, Andrew |
|
|
400 |
10349 |
p. 354 |
artikel |
25 |
Violence against health workers rises during COVID-19
|
Thornton, Jacqui |
|
|
400 |
10349 |
p. 348 |
artikel |